Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation.

[1]  I. Guella,et al.  Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency , 2015, Thrombosis and Haemostasis.

[2]  A. Lebreton,et al.  Natural history of patients with congenital dysfibrinogenemia. , 2015, Blood.

[3]  A. Casini,et al.  Congenital Fibrinogen Disorders: An Update , 2013, Seminars in Thrombosis & Hemostasis.

[4]  Rustem I. Litvinov,et al.  Mechanisms of fibrin polymerization and clinical implications. , 2013, Blood.

[5]  Raja Mazumder,et al.  Structure-based Comparative Analysis and Prediction of N-linked Glycosylation Sites in Evolutionarily Distant Eukaryotes , 2013, Genom. Proteom. Bioinform..

[6]  E. Rapp,et al.  Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation. , 2012, Journal of proteome research.

[7]  S. Duga,et al.  Congenital hypofibrinogenemia: characterization of two missense mutations affecting fibrinogen assembly and secretion. , 2008, Blood cells, molecules & diseases.

[8]  S. Acharya,et al.  Rare inherited disorders of fibrinogen , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  M. Neerman-Arbez,et al.  Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins , 2007, Journal of thrombosis and haemostasis : JTH.

[10]  P. de Moerloose,et al.  Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of 10 novel mutations , 2007, Human mutation.

[11]  Guillaume Vogt,et al.  Gain-of-glycosylation mutations. , 2007, Current opinion in genetics & development.

[12]  S. Duga,et al.  The molecular basis of quantitative fibrinogen disorders , 2006, Journal of thrombosis and haemostasis : JTH.

[13]  D. Triplett,et al.  Thrombophilias and recurrent pregnancy loss. , 2006, Seminars in reproductive medicine.

[14]  M. Bertrand,et al.  LETTERS TO THE EDITOR: Four cases of hypofibrinogenemia associated with four novel mutations , 2005, Journal of thrombosis and haemostasis : JTH.

[15]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[16]  S. Brennan,et al.  Novel γ230 Asn→Asp substitution in fibrinogen Middlemore associated hypofibrinogenaemia , 2005, Thrombosis and Haemostasis.

[17]  B. Kudryk,et al.  Fibrinogen Biosynthesis , 2001, Thrombosis and Haemostasis.

[18]  V. V. van Hinsbergh,et al.  Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aalpha-chain, alters endothelial capillary tube formation. , 2001, Blood.

[19]  B. Lämmle,et al.  Fibrinogen Milano XIII (Aα 19 Arg→Gly) , 1999 .

[20]  J. Mimuro,et al.  Fibrinogen Niigata With Impaired Fibrin Assembly: An Inherited Dysfibrinogen With a Bβ Asn-160 to Ser Substitution Associated With Extra Glycosylation at Bβ Asn-158 , 1999 .

[21]  S. Brennan,et al.  Oligosaccharide Configuration of Fibrinogen Kaiserslautern: Electrospray Ionisation Analysis of Intact γ Chains , 1998, Thrombosis and Haemostasis.

[22]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[23]  B. Lämmle,et al.  A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III. , 1994, The Journal of biological chemistry.

[24]  S. Lord,et al.  Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids A alpha 461-610 (Lys 461 AAA-->stop TAA) , 1992 .

[25]  P. Mannucci,et al.  Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma , 1992, British journal of haematology.

[26]  H. Hirata,et al.  Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator. , 1992, The Journal of clinical investigation.

[27]  H. Hirata,et al.  An A alpha Ser-434 to N-glycosylated Asn substitution in a dysfibrinogen, fibrinogen Caracas II, characterized by impaired fibrin gel formation. , 1991, The Journal of biological chemistry.

[28]  J. Nickerson,et al.  Modification of fibrinogen chains during synthesis: glycosylation of B beta and gamma chains. , 1981, Biochemistry.

[29]  S. Shapiro,et al.  Fibrinogen Philadelphia. A hereditary hypodysfibrinogenemia characterized by fibrinogen hypercatabolism. , 1974, The Journal of clinical investigation.

[30]  W. Nieuwenhuizen.  Fibrinogen : XVIth International Fibrinogen Workshop , 2001 .

[31]  R. Colman.  Hemostasis and thrombosis: Basic principles and clinical practice , 1987 .